Conference | Mixed
Event Title
2026 PDA/FDA Joint Regulatory Conference
September 14 - 16, 2026
- Date:
- September 14 - 16, 2026
- Day1:
- Mon, Sep 14 7:00 a.m. - 06:00 p.m. ET
- Day2:
- Tue, Sep 15 7:00 a.m. - 06:00 p.m. ET
- Day3:
- Wed, Sep 16 7:00 a.m. - 03:30 p.m. ET
About
FDA and Parenteral Drug Association (PDA) will host the 2026 PDA/FDA Joint Regulatory Conference, Excellence in CGMP: Ensuring Quality, Protecting Patients, in Washington, D.C.
The conference will offer practical insights on current good manufacturing practice (CGMP) compliance, quality systems, risk-based manufacturing, supply chain oversight and industrial modernization through expert-led discussions and real-world case studies.
The conference will explore regulatory priorities, emerging technologies and quality challenges through expert-led discussions, case studies and direct engagement with regulators and industry leaders.
Topics will include:
- FDA Center and Office Updates
- AI in Regulatory Oversight and Inspection Readiness
- Inspection Readiness and Pre-Approval Inspections
- Corrective and Preventive Action (CAPA) and Effectiveness Checks
- Data Governance and Quality Risk Management
- Change Management and Quality Systems
- Workforce Development and CGMP Training
- Global Regulatory Collaboration
Visit the PDA/FDA Joint Regulatory Conference 2026 webpage for additional information.
Who should attend:
- Quality assurance and quality systems professionals
- Regulatory affairs and compliance leaders
- CGMP manufacturing and technical operations professionals
- Validation, auditing and inspection readiness professionals
- Data governance and digital quality leaders
- Supplier quality and external partner professionals
- FDA and global health authority representatives
- Cross-functional quality and compliance professionals